Panakeia, a DigitalHealth.London Accelerator alumnus company, is part of the second phase of the MHRA AI Airlock. Vishali Sharma-Mühlendorfer, VP of Biopharma and Regulatory, tells us about being selected for this pioneering initiative and the company’s aims for…
Continue Reading
Nicole Ventrone, Partner at Beghou
Pharma is embracing GPT-5, shifting AI from chatbot to enterprise agent as it accelerates productivity amid regulatory challenges.
Large pharmaceutical and biotech companies have spent the last couple of years running…
Continue Reading
Background: The mental health app sector in India is expanding rapidly, driven by increasing smartphone usage, growing internet penetration, the popularity of digital initiatives, and heightened recognition of mental health challenges in public discourse….
Continue Reading
The Driving Force Behind Cloud Repatriation
Although only 8%-9% of organizations intend to implement full workload repatriation, the cost and regulatory challenges driving the trend are real, according to IDC’s recent Server and Storage Workloads…
The Evolving Orphan Drug Landscape
Once considered specialized treatments for rare conditions, orphan drugs are now challenging the dominance of mainstream medications in the pharmaceutical industry. According to two recent Evaluate reports—”Are Orphans That Different?”…
